Live feed
Filing
SC 13G/A
SC 13G/A0001929354-23-000017·Avalo Therapeutics, Inc.
Schedule 13G ownership disclosure
Avalo Therapeutics, Inc.
Security class unavailable · CUSIP: 05338F108
Event date: 2023-06-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 0
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001929354-23-000017
- Form type
- SC 13G/A
- Filer
- Avalo Therapeutics, Inc.
- CIK
- CIK 1534120
- Filed
- Jun 29, 2023
- Reporting period
- Jun 26, 2023
- Description
- Schedule 13G beneficial ownership